Megestrol Acetate Induces Declarative Memory Changes and Cortisol Suppression in Healthy Volunteers

Dement Geriatr Cogn Disord. 2018;46(3-4):186-192. doi: 10.1159/000490789. Epub 2018 Oct 4.

Abstract

Background: The effects of the glucocorticoid and progesterone receptor agonist megestrol on declarative memory, and the ability of phenytoin to block these effects, were assessed.

Methods: Healthy volunteers received each medication combination (placebo and megestrol, phenytoin and megestrol, and placebo and placebo) using a randomized, crossover design. The Rey Auditory Verbal Learning Test assessed declarative memory.

Results: Megestrol was associated with a significant reduction in declarative memory (p = 0.0008), which was attenuated by phenytoin, and was associated with significant cortisol suppression compared to placebo (p < 0.001).

Conclusion: Changes in memory and cortisol suppression were found in healthy volunteers given megestrol.

Keywords: Corticosteroid; Megestrol; Memory; Phenytoin.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Appetite Stimulants / administration & dosage
  • Appetite Stimulants / adverse effects
  • Cognition / drug effects
  • Cross-Over Studies
  • Drug Monitoring
  • Female
  • Healthy Volunteers
  • Humans
  • Hydrocortisone / blood*
  • Male
  • Megestrol Acetate* / administration & dosage
  • Megestrol Acetate* / adverse effects
  • Memory / drug effects*
  • Phenytoin / administration & dosage
  • Phenytoin / adverse effects
  • Receptors, Progesterone / agonists
  • Treatment Outcome

Substances

  • Appetite Stimulants
  • Receptors, Progesterone
  • Phenytoin
  • Megestrol Acetate
  • Hydrocortisone